Detalhe da pesquisa
1.
Reaching the target dose with one single 131 I-mIBG administration in high-risk neuroblastoma: The determinant impact of the primary tumour.
Pediatr Blood Cancer
; 71(3): e30806, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38082548